State-funded venture capital firm Connecticut Innovations has launched a $200m fund to stimulate the state’s bioscience sector.
Grants, equity investments and loans will all be available to bioscience-related ventures over the next ten years, following the passing of Senate Bill 842. The funds will be primarily be used to assist startups and university spin-outs cross the valley of death from the proof-of-concept stage and onwards, filling the gap that traditional venture funds steer away from.
The fund is…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?